Skip to content
The GLP-1 Verdict
Menu
Ranked #425 · Grade C

Peter MD review

A physician-prescribed telehealth brand with tiered semaglutide pricing and a discounted tirzepatide first month — restrictions vary by treatment, excluding several states, and its own marketing page understates them.

Pricing last checked on Peter MD's own site .

Visit Peter MD Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
$149/mo first-time, $139/mo returning
Tirzepatide
$149 first month, then $249/mo thereafter, billed quarterly
Coverage
Most states — excludes AL, ID and up to 5 more depending on treatment
Brand-name
Compounded only

The scorecard

Peter MD scored on our six published factors. See the methodology.

Real-world results58/100
Price honesty42/100
Prescriber access60/100
Formulary choice45/100
Cancellation fairness50/100
Member support55/100

What we like

  • Physician-prescribed telehealth model, founded 2021, headquartered in Miami, FL
  • Semaglutide is priced in two published tiers, and returning patients pay less than first-time patients ($139/mo vs $149/mo)
  • Tirzepatide's discounted first month ($149) is stated up front rather than buried in fine print

The caveats

  • The affiliate program's own disclosed restricted-state list is broader than the customer-facing pricing pages: tirzepatide is additionally excluded in AR, CA, MI, NC and TX beyond the AL/ID the marketing page names, and the two disclosures do not agree
  • Tirzepatide's price nearly doubles after the first month, from $149 to $249/mo, billed quarterly
  • Semaglutide is sold combined with B12 as "GLP1 + B12," not offered as a standalone prescription
  • No oral or sublingual option — injectable only
  • Customer reviews are mixed

The verdict

Best for: Patients outside the excluded states who want tiered semaglutide pricing or a discounted tirzepatide first month from a physician-founded telehealth brand. A physician-prescribed telehealth brand with tiered semaglutide pricing and a discounted tirzepatide first month — restrictions vary by treatment, excluding several states, and its own marketing page understates them.

Ranked #425 of 539 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. In the ranking it sits between Nouri at #424, 55/100 above and WellMedr at #426, 52/100 below, with the FORM (by GBY) ruling the next one down.

If that ruling leaves you undecided, the 7 programs we rank against Peter MD are graded on the same six factors and listed in score order.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Peter MD goes to CoreAge Rx, 94/100 to 52/100.

Compare with other providers

The closest rulings to Peter MD by Verdict Score — the realistic shortlist if you are weighing this one up.

Browse all 539 rulings, ranked →

Pricing, states and verification reflect Peter MD's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Peter MD's site. Not medical advice; see our disclosure.

← Back to all rankings